{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreihlmvv77ctxjyh2dqyiuiekwvv7xwp7gpsjtrzvy235h2tskopbka",
    "uri": "at://did:plc:pmmp7irwts7faw56jdxk3idc/app.bsky.feed.post/3mjwxnpougwk2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreihtazfyscy2xui64vwkegloxn33m27v62rgpn5tds2a57gn3ij4im"
    },
    "mimeType": "image/jpeg",
    "size": 194503
  },
  "path": "/news/2026-04-aacr-platform-machine-responses-patients.html",
  "publishedAt": "2026-04-20T13:00:08.000Z",
  "site": "https://medicalxpress.com",
  "textContent": "An artificial intelligence (AI) model developed by researchers at The University of Texas MD Anderson Cancer Center demonstrated the ability to accurately predict responses to immunotherapy for patients with metastatic non-small cell lung cancer (NSCLC). If clinically validated, it could give clinicians much-needed insight into one of the most pressing challenges in oncology.",
  "title": "AACR: New platform uses machine learning to predict responses in patients with lung cancer"
}